Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity RatioInvested Capital

Alterity Therapeutics (ATHE) Assets Average (2016 - 2025)

Alterity Therapeutics has reported Assets Average over the past 5 years, most recently at $5.1 billion for Q2 2019.

  • For Q2 2019, Assets Average rose 32635.95% year-over-year to $5.1 billion; the TTM value through Jun 2019 reached $5.1 billion, up 32635.95%, while the annual FY2016 figure was $28.9 billion, N/A changed from the prior year.
  • Assets Average for Q2 2019 was $5.1 billion at Alterity Therapeutics, roughly flat from $5.1 billion in the prior quarter.
  • Over five years, Assets Average peaked at $16.3 billion in Q4 2015 and troughed at $15.5 million in Q2 2018.
  • A 5-year average of $8.8 billion and a median of $9.5 billion in 2017 define the central range for Assets Average.
  • Biggest five-year swings in Assets Average: crashed 99.84% in 2018 and later skyrocketed 32635.95% in 2019.
  • Year by year, Assets Average stood at $16.3 billion in 2015, then fell by 22.57% to $12.6 billion in 2016, then decreased by 24.59% to $9.5 billion in 2017, then crashed by 46.54% to $5.1 billion in 2018, then fell by 0.0% to $5.1 billion in 2019.
  • Business Quant data shows Assets Average for ATHE at $5.1 billion in Q2 2019, $5.1 billion in Q4 2018, and $15.5 million in Q2 2018.